STUDIES ON ABSORPTION, DISTRIBUTION, METABOLISM AND EXCRETION OF CEFTAZIDIME IN JAPAN

被引:18
作者
SAITO, A
机构
关键词
D O I
10.1093/jac/12.suppl_A.255
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:255 / 262
页数:8
相关论文
共 10 条
[1]  
ACRED P, 1981, FUTURE TRENDS CHEMOT, V4, P51
[2]  
CRAIG WA, 1980, CLIN THER, V3, P46
[3]   CEFTIZOXIME KINETICS AND RENAL HANDLING [J].
DUBB, J ;
ACTOR, P ;
PITKIN, D ;
ALEXANDER, F ;
FAMILIAR, R ;
EHRLICH, S ;
STOTE, R .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (04) :516-521
[4]  
GOZZARD DI, 1982, LANCET, V1, P1152
[5]   THE COMPARATIVE PHARMACOKINETICS OF CEFTAZIDIME AND CEFOTAXIME IN HEALTHY-VOLUNTEERS [J].
HARDING, SM ;
MONRO, AJ ;
THORNTON, JE ;
AYRTON, J ;
HOGG, MIJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :263-272
[6]  
HARPER PB, 1980, CURRENT CHEMOTHERAPY, P269
[7]   COMPARATIVE MULTIPLE-DOSE PHARMACOKINETICS OF CEFOTAXIME, MOXALACTAM, AND CEFTAZIDIME [J].
LUTHY, R ;
BLASER, J ;
BONETTI, A ;
SIMMEN, H ;
WISE, R ;
SIEGENTHALER, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (05) :567-575
[8]   GR 20263, A NEW BROAD-SPECTRUM CEPHALOSPORIN WITH ANTI-PSEUDOMONAL ACTIVITY [J].
OCALLAGHAN, CH ;
ACRED, P ;
HARPER, PB ;
RYAN, DM ;
KIRBY, SM ;
HARDING, SM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (05) :876-883
[10]  
UEDA Y, 1980, CHEMOTHERAPY-TOKYO, V28, P370